Mukhamedaliev, Umar; Galle, Peter R.; Strand., Susanne
Modulation of mitotic stress-induced activation of the cGAS/ STING signaling pathway by DNA demethylationJOURNAL OF HEPATOLOGY. Bd. 82. 2025
Gairing, Simon Johannes; Schleicher, Eva Maria; Meineck, Myriam et al.
Neurofilament light chains and glial fibrillary acidic protein in serum for predicting post-TIPS hepatic encephalopathyJOURNAL OF HEPATOLOGY. Bd. 82. 2025
Labenz, Christian; Schleicher, Eva Maria; Meineck, Myriam et al.
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyMEDCOMM. Bd. 6. H. 11. 2025
Melero, Ignacio; de Miguel Luken, Maria; de Velasco, Guillermo et al.
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursNATURE. Bd. 637. H. 8048. 2025
Melero, Ignacio; de Miguel Luken, Maria; de Velasco, Guillermo et al.
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours (vol 637, pg 1218, 2025)NATURE. Bd. 639. H. 8054. 2025 S. E18-E18
Kudo, Masatoshi; Yau, Thomas; Decaens, Thomas et al.
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) therapy for unresectable hepatocellular carcinoma (uHCC): CheckMate 9DW expanded analyses.JOURNAL OF CLINICAL ONCOLOGY. Bd. 43. H. 4_SUPPL. 2025 S. 520-520
Yau, Thomas; Galle, Peter R.; Decaens, Thomas et al.
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3trialLANCET. Bd. 405. H. 10492. 2025 S. 1851-1864
Triantafyllias, Konstantinos; Bach, Mirjam; Boegel, Sebastian et al.
Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjogren's: the SICARD cohort studyARTHRITIS RESEARCH & THERAPY. Bd. 27. H. 1. 2025
Triantafyllias, K.; Bach, M.; Boegel, S. et al.
OSCILLOMETRIC, GREYSCALE, AND NOVEL COLOR-DOPPLER ULTRASOUND MARKERS OF MACROVASCULAR DAMAGE IN SJOGREN'S SYNDROME: FINDINGS FROM THE SICARD COHORT STUDYANNALS OF THE RHEUMATIC DISEASES. Bd. 84. 2025
Sangro, Bruno; Kudo, Masatoshi; Decaens, Thomas et al.
Outcomes by liver function in patients with unresectable hepatocellular carcinoma treated with nivolumab plus ipilimumab vs lenvatinib or sorafenib in the CheckMate 9DW trialJOURNAL OF HEPATOLOGY. Bd. 82. 2025